Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Johnson & Johnson (NY:JNJ)

218.86 +0.37 (+0.17%)

Streaming Delayed Price Updated: 1:27 PM EST, Jan 23, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,647,237
Open	219.80
Bid (Size)	218.81 (100)
Ask (Size)	218.91 (100)
Prev. Close	218.49
Today's Range	217.84 - 220.48
52wk Range	141.50 - 222.17
Shares Outstanding	2,628,679,824
Dividend Yield	2.38%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

2 Soaring Stocks to Hold for the Next 20 Years ↗

Today 12:50 EST

They can power outstanding returns while providing stability to a well-diversified portfolio.

Via The Motley Fool

The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare

Today 12:17 EST

The healthcare landscape underwent a seismic shift in 2024, as the industry’s major players pivoted away from traditional hardware toward high-margin diagnostic platforms and artificial intelligence...

Via MarketMinute

Performance

YTD	+5.6%	+5.6%
1 Month	+6.4%	+6.4%
3 Month	+13.7%	+13.7%
6 Month	+29.1%	+29.1%
1 Year	+50.7%	+50.7%

More News

Johnson & Johnson Quietly Triggers a Trend Following Buy Signal ↗

Today 11:24 EST

Via MarketBeat

Stability Meets Scale: Why Johnson & Johnson is Poised for a Breakout 2026

Today 10:19 EST

Via MarketMinute

Is This Dividend King a Screaming Buy? ↗

Today 5:04 EST

Via The Motley Fool

The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market

January 22, 2026

Via MarketMinute

I Correctly Predicted That These 15 Dow Jones Stocks Would Boost Their Payouts in 2025. Here's Why It Can Happen Again in 2026. ↗

January 22, 2026

Via The Motley Fool

Johnson & Johnson (NYSE:JNJ) Beats Q4 Estimates but Stock Dips on 2026 Guidance ↗

January 21, 2026

Via Chartmill

Resilience in the Face of the Patent Cliff: Johnson & Johnson Forecasts Landmark 2026 Growth

January 22, 2026

Via MarketMinute

Johnson & Johnson Analyst Raises Price Target On Several Tailwinds In 2026 ↗

January 22, 2026

Via Benzinga

The Davos Pivot: Trump’s Tariff U-Turn Sends Markets Into a Greenland Glow ↗

January 22, 2026

Via Chartmill

This 2.4%-Yielding Dividend King Remains As Healthy As Ever ↗

January 22, 2026

Via The Motley Fool

S&P 500 Jumps Over 1% As Trump Withdraws EU Tariff Threat: Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral' Zone ↗

January 22, 2026

Via Benzinga

Is This Dividend King Stock a Buy After a Major Development? ↗

January 21, 2026

Via The Motley Fool

J&J Forecasts $100 Billion Milestone for 2026 as Trump Drug Pricing Deals Reshape the Pharma Landscape

January 21, 2026

Via MarketMinute

Johnson & Johnson (JNJ) Earnings Call Transcript ↗

January 21, 2026

Via The Motley Fool

Discover the top S&P500 movers in Wednesday's pre-market session. ↗

January 21, 2026

Via Chartmill

Johnson & Johnson Posts Q4 2025 Revenue Beat, EPS Comes Up Short ↗

January 21, 2026

Via Talk Markets

Johnson & Johnson reports Q4 and Full-Year 2025 results

January 21, 2026

From Johnson & Johnson

Via Business Wire

Nasdaq, S&P 500 Futures Rebound, All Eyes On Trump’s Davos Speech: Why TSLA, NVDA, NFLX, AVR Are On Traders' Radar Today ↗

January 21, 2026

Via Stocktwits

Dow, Nasdaq, S&P 500 Futures Tick Higher After Wall Street’s Worst Day In 3 Months: Why NFLX, AAPL, CRVS, GME, UAL Are In Focus Today ↗

January 20, 2026

Via Stocktwits

The Titan’s Balance: Johnson & Johnson Reaches Record Highs Amidst Legal Hurdles and Med-Tech Transformation

January 20, 2026

Via MarketMinute

The New Titan of Wellness: Kimberly-Clark’s $48.7 Billion Kenvue Acquisition Reshapes Consumer Staples

January 20, 2026

Via MarketMinute

The M&A Renaissance: 2026 Set to Eclipse a Record-Breaking 2025 as AI and Regulatory Clarity Drive Deal Supercycle

January 20, 2026

Via MarketMinute

The High-Stakes Balancing Act: Johnson & Johnson Braces for Q4 Earnings Amid Patent Cliffs and MedTech Expansion

January 20, 2026

Via MarketMinute

Frequently Asked Questions

Is Johnson & Johnson publicly traded?

Yes, Johnson & Johnson is publicly traded.

What exchange does Johnson & Johnson trade on?

Johnson & Johnson trades on the New York Stock Exchange

What is the ticker symbol for Johnson & Johnson?

The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange

What is the current price of Johnson & Johnson?

The current price of Johnson & Johnson is 218.86

When was Johnson & Johnson last traded?

The last trade of Johnson & Johnson was at 01/23/26 01:27 PM ET

What is the market capitalization of Johnson & Johnson?

The market capitalization of Johnson & Johnson is 575.31B

How many shares of Johnson & Johnson are outstanding?

Johnson & Johnson has 575B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.